REFERENCES
239
9. Yang XF. Immunology of stem cells and cancer stem cells. Cell Mol Immunol. 2007; 4:161–171. 10. Grandics P. The cancer stem cell: evidence for its origin as an injured autoreactive T cell. Mol Cancer. 2006; 5:6. 11. Groux H, Cottrez F. The complex role of interleukin-10 in autoimmunity. J Autoimmun. 2003; 20:281–285. 12. Pellegris G, Ravagnani F, Notti P, Fissi S, Lombardo C. B and C hepatitis viruses, HLA-DQI and -DR3 alleles and autoimmunity in patients with hepatocellular carcinoma. J Hepatol. 2002; 36:521–526. 13. Venables P. Epstein–Barr virus infection and autoimmunity in rheumatoid arthritis. Ann Rheum Dis. 1988; 47:265–269. 14. Andreev VC, Zlatkov NB. Systemic lupus erythematosus and neoplasia of the lymphoreticular system. Br J Dermatol. 1968; 80:503–508. 15. Mueller N, Hinkula J, Wahren B. Elevated antibody titers against cytomegalovirus among patients with testicular cancer. Int J Cancer. 1988; 41:399–403. 16. Gupta V, Eden AJ, Mills MJ. Helicobacter pylori and autoimmune neutropenia. Clin Lab Haematol. 2002; 24:183–185. 17. Pedersen AE. The potential for induction of autoimmune disease by a randomly mutated self antigen. Med Hypothesis. 2007; 68:1240–1246. 18. Harris HF. A case of diabetes mellitus quickly following mumps. Boston Med Surg J. 1898; 140:465–469. 19. Ginsberg-Fellner F, Witt ME, Yagihashi S, et al. The interrelationship of congenital rubella. Diabetologia. 1984; 27:87–89. 20. Gamble DR, Taylor KW, Cumming H. Coxsackie viruses and diabetes mellitus. Br Med J. 1973; 4:260–262. 21. Hiemstra HS, Schloot NC, Veelen PA. Cytomegalovirus in autoimmunity: T cell cross reactivity to viral antigen and autoantigens to glutamic acid decarboxylase. Proc Natl Acad Sci U S A. 2001; 98:398–399. 22. Shi F, Ljunggren HG, Sarvetnick N. Innate immunity and autoimmunity: from self-protection to self-destruction. Trends Immunol. 2001; 22:97–101. 23. Pircher H, Rohrer UH, Moskophidis D, Zinkernagel RM, Hengartner H. Lower receptor avidity required for thymic clonal deletion than for effector T-cell function. Nature. 1991; 351:482–485. 24. Sandberg JK, Franksson L, Sundback J, et al. T cell tolerance based on avidity thresholds rather than complete deletion allows maintenance of maximal repertoire diversity. J Immunol. 2000; 165:25–33. 25. Strasser A, Whittingham S, Vaux DL, et al. Enforced BCL2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease. Proc Natl Acad Sci U S A. 1991; 88:8661–8665. 26. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature. 1992; 356:314–317. 27. Grodzicky T, Elkon KB. Apoptosis: a case where too much or too little can lead to autoimmunity. Mount Sinai J Med. 2002; 69:208–219. 28. Sachs L. The control of hematopoiesis and leukaemia: from basic biology to the clinic. Proc Natl Acad Sci U S A. 1996, 93:4742–4749.